Middlebury

 

Presentation Title: Effect of NMDA receptor blockade, neurosteroid administration and operant response option on schizophrenia-like cognitive deficits.

Section: Advances in Health and Harm Reduction I

Location: McCardell Bicentennial Hall, 220

Date & Time: Friday, April 19, 2013 - 9:35am - 9:50am

Abstract:

Schizophrenia is a debilitating psychiatric disorder characterized in part by impaired cognition. One such deficit is cognitive flexibility, the ability to shift between rules or behavioral strategies as circumstances require. We investigated whether a GABA receptor positive modulator, the neurosteroid allopregnanolone, could alleviate cognitive flexibility deficits induced by the NMDA glutamate receptor antagonist MK-801. MK-801 administration induces cognitive deficits resembling those seen in schizophrenia. Male rats were trained on an operant task requiring them first to learn a discrimination rule based on either the presence of a lighted response key, or the location of a response key in the test chamber. Rats were then given injections of a control solution, MK-801, or allopregnanolone, alone or in combination, and trained on the alternative discrimination rule. Results suggest that MK-801 impaired cognitive flexibility relative to controls, and allopregnanolone, when co-administered with MK-801, alleviated cognitive deficits, but only in controlled-access response modules.   

Type of Presentation: Individual oral

Oral presenters
Presentation Area: Neuroscience

Presentation Topic: Science & Technology

Arts presenters
Format: 

Class Project
Course name: 
Course Instructor: 
Number of presenters: 

Presenter Information
Presenter(s): Sackett, Deirdre
Major(s): Neuroscience
Class Year(s): 2013

Sponsor(s): Stefani, Mark R.
Dept(s): Dept. of Psychology, Program in Neuroscience

Moderator: ,